Mark Kiel

Co-Founder, Chief Scientific Officer
Genomenon
Mark Kiel
Dr. Kiel completed his MD/PhD and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he supervises the scientific direction of the Mastermind suite of software tools.

Sessions

No data was found

Other Speakers